These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18857554)

  • 1. [Parpanit in the treatment of intentional tremor; multiple sclerosis and upper red kernel syndrome].
    BICKEL G; DUBOIS JP
    Rev Med Suisse Romande; 1947 Oct; 67(10):708-16. PubMed ID: 18857554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the effect of parpanit on motility disorders from extrapyramidal and pyramidal lesions].
    DAVINI V; BORELLINI A
    Minerva Med; 1948 Oct; 39(43 Pt 2):432-5. PubMed ID: 18103536
    [No Abstract]   [Full Text] [Related]  

  • 3. Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit.
    SCHWAB RS; TILLMANN WR
    N Engl J Med; 1949 Sep; 241(13):483-5. PubMed ID: 18140791
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of Parkinson's syndrome with parpanite].
    BOOIJ J
    Ned Tijdschr Geneeskd; 1948 Apr; 92(14):994-1000. PubMed ID: 18872076
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing tremor reduction and quality of life following thalamic deep brain stimulation for the treatment of tremor in multiple sclerosis.
    Berk C; Carr J; Sinden M; Martzke J; Honey CR
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1210; author reply 1210-1. PubMed ID: 15258245
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.
    Oliveria SF; Rodriguez RL; Bowers D; Kantor D; Hilliard JD; Monari EH; Scott BM; Okun MS; Foote KD
    Lancet Neurol; 2017 Sep; 16(9):691-700. PubMed ID: 28642125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tremor in multiple sclerosis.
    Koch M; Mostert J; Heersema D; De Keyser J
    J Neurol; 2007 Feb; 254(2):133-45. PubMed ID: 17318714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-deep brain stimulation--gradual non-stimulation dependent decrease in strength with attenuation of multiple sclerosis tremor.
    Hyam JA; Aziz TZ; Bain PG
    J Neurol; 2007 Jul; 254(7):854-60. PubMed ID: 17431703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesodiencephalic targeting of stimulating electrodes in patients with tremor caused by multiple sclerosis.
    Whittle IR; Yau YH; Hooper J
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1210. PubMed ID: 15258244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intentional hyperkinesis].
    Iwata M
    No To Shinkei; 1976 May; 28(5):422-8. PubMed ID: 1036061
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
    Thompson AJ; Peng-Chen Z; Pastrana M; Foote KD; Haq I; Okun MS
    Neurocase; 2014; 20(6):698-703. PubMed ID: 24156388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morbus Little treated with parpanite].
    JERSILD T
    Ugeskr Laeger; 1949 Apr; 111(16):449-51. PubMed ID: 18151545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tremor and abnormal movement in multiple sclerosis: symptomatic therapeutic indications].
    Viallet F; Witjas T; Gayraud D; Pelletier J; Regis J
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1079-84. PubMed ID: 11787340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of intention tremor by contingent deep-brain stimulation.
    Brice J; McLellan L
    Lancet; 1980 Jun; 1(8180):1221-2. PubMed ID: 6104038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parpanite treatment of paralysis agitans].
    DALSGAARD-NIELSEN T
    Ugeskr Laeger; 1949 Apr; 111(16):446. PubMed ID: 18151543
    [No Abstract]   [Full Text] [Related]  

  • 16. [About parpanite; treatment results spec. by encephalitic parkinsonism].
    HERMANN K
    Ugeskr Laeger; 1949 Apr; 111(16):447-9. PubMed ID: 18151544
    [No Abstract]   [Full Text] [Related]  

  • 17. [About the preparation parpanite; used for 30 patients with Parkinsonism].
    MUNCH-PETERSEN S
    Ugeskr Laeger; 1949 Apr; 111(16):443-5. PubMed ID: 18151542
    [No Abstract]   [Full Text] [Related]  

  • 18. Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis.
    Marrosu F; Maleci A; Cocco E; Puligheddu M; Marrosu MG
    Neurology; 2005 Aug; 65(3):490. PubMed ID: 16087927
    [No Abstract]   [Full Text] [Related]  

  • 19. Permanent tremor reduction during thalamic stimulation in multiple sclerosis.
    Thevathasan W; Schweder P; Joint C; Ray N; Pretorius P; Gregory R; Aziz T
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):419-22. PubMed ID: 20884671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of upper limb ataxia and intention tremor allowing cessation of thalamic electrostimulation after four years.
    Moringlane JR; Spiegel J; Fuss G; Dillmann U; Pützer M; Sittinger H
    Mult Scler; 2004 Dec; 10(6):708-10. PubMed ID: 15584498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.